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Summary
Mutations in the nuclear envelope protein lamin A or in
its processing protease ZMPSTE24 cause human acceler-
ated aging syndromes, including Hutchinson–Gilford pro-
geria syndrome. Similarly, Zmpste24-deficient mice
accumulate unprocessed prelamin A and develop multiple
progeroid symptoms, thus representing a valuable animal
model for the study of these syndromes. Zmpste24-defi-
cient mice also show marked transcriptional alterations
associated with chromatin disorganization, but the
molecular links between both processes are unknown.
We report herein that Zmpste24-deficient mice show a
hypermethylation of rDNA that reduces the transcription
of ribosomal genes, being this reduction reversible upon
treatment with DNA methyltransferase inhibitors. This
alteration has been previously described during physio-
logical aging in rodents, suggesting its potential role
in the development of the progeroid phenotypes. We
also show that Zmpste24-deficient mice present global
hypoacetylation of histones H2B and H4. By using a
combination of RNA sequencing and chromatin immuno-
precipitation assays, we demonstrate that these histone
modifications are associated with changes in the expres-
sion of several genes involved in the control of cell pro-
liferation and metabolic processes, which may contribute
to the plethora of progeroid symptoms exhibited by
Zmpste24-deficient mice. The identification of these
altered genes may help to clarify the molecular mecha-
nisms underlying aging and progeroid syndromes as well
as to define new targets for the treatment of these
dramatic diseases.
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Introduction
Hutchinson–Gilford progeria syndrome (HGPS) is an accelerated
aging process characterized by short stature, low body weight,
early hair loss, lack of subcutaneous fat, scleroderma, decreased
joint mobility, osteolysis, atherosclerosis, and premature death
(Hennekam, 2006; Merideth et al., 2008). Hutchinson–Gilford
progeria syndrome belongs to an array of human disorders col-
lectively known as laminopathies, caused by defects in compo-
nents of the nuclear lamina and including Emery-Dreifuss
muscular dystrophy, limb-girdle muscular dystrophy, dilated car-
diomyopathy, Charcot-Marie-Tooth disease, Dunningan-type
familial partial lipodystrophy, and mandibuloacral dysplasia
(Navarro et al., 2006; Ramirez et al., 2007). Around 80% of
patients with HGPS have the same de novo silent point mutation
(G608G: GGC->GGT) in exon 11 of LMNA gene that encodes
lamins A and C. This mutation activates a cryptic donor splice
site, eliminating 150 bp of exon 11 and generating a trun-
cated lamin A isoform known as progerin ⁄ LAdelta50 (De
Sandre-Giovannoli et al., 2003; Eriksson et al., 2003).
Lamin A post-translational processing includes prenylation,
cleavage of the C-terminal tripeptide, methylation of the
prenylated C-terminal cysteine residue, and finally, the proteo-
lytic removal of the C-terminal prenylated peptide by the
metalloproteinase FACE-1 ⁄ ZMPSTE24 (Pendas et al., 2002).
The target sequence of this last proteolytic event is included in
the region deleted in progerin, and consequently progerin
undergoes normally the initial steps of lamin A maturation but
the prenylated peptide cannot be excised. Thus, the HGPS
mutation causes the accumulation of permanently prenylated
progerin, which leads to structural alterations in the nuclear
envelope and its associated chromatin (De Sandre-Giovannoli
et al., 2003; Eriksson et al., 2003). Similarly, disruption of the
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murine Zmpste24 gene prevents the cleavage of the lamin A
prenylated peptide, leading to the accumulation of farnesylated
prelamin A in the nuclear envelope. Prelamin accumulation in
Zmpste24-deficient mice causes nuclear architecture abnormali-
ties, shortened lifespan, and a progeroid phenotype that reca-
pitulates most HGPS symptoms (Bergo et al., 2002; Pendas
et al., 2002). Consequently, Zmpste24-deficient mice constitute
a valuable animal model to study the mechanisms underlying
the development of progeroid syndromes and to investigate
possible therapeutic approaches for these pathologies. The
transcriptional profiles of Zmpste24-deficient tissues and HGPS
cells have been investigated, leading to the identification of
signaling alterations that could be implicated in the onset of the
progeroid phenotypes (Csoka et al., 2004; Varela et al., 2005;
Osorio et al., 2009). Significantly, the production of progerin,
accompanied by some of these transcriptional alterations, has
been detected in the context of physiological aging (Scaffidi &
Misteli, 2006). These findings support the use of progeroid
animal models such as Zmpste24-deficient mice to investigate
the molecular mechanisms underlying the manifestations of
normal and pathological aging. Nevertheless, despite the
intense research in this field, little is known about the link
between the alterations in nuclear structure and dynamics and
the transcriptional deregulation detected in laminopathies. As
nuclear structure is essential for a correct epigenetic pattern
and because anomalous epigenetic signaling could be an impor-
tant determinant of cellular senescence and organism aging
(Issa, 2003; Sinclair & Oberdoerffer, 2009; Gravina & Vijg,
2010), we hypothesized that epigenetic alterations could be
involved in the development of HGPS symptoms. In agreement
with this hypothesis, changes in the methylation pattern of his-
tone H3 have been recently described in HGPS cells but the rele-
vance of these changes remains largely unknown (Scaffidi &
Misteli, 2005; Shumaker et al., 2006; Dechat et al., 2008).
In the present work, we describe that the abnormalities in
nuclear structure and dynamics caused by Zmpste24-deficiency
lead to the accumulation of characteristic epigenetic marks such
as rDNA hypermethylation and histone hypoacetylation. Based
on these findings, together with the observation that similar
abnormalities also occur during physiological aging, we propose
that chromatin disorganization generates a characteristic aging-
like epigenetic pattern which contributes to the transcriptional
deregulation associated with both normal and accelerated
aging.
Results
Zmpste24-deficiency causes hypermethylation of
ribosomal DNA
DNA methylation and histone post-translational modifications
are the most widely analyzed epigenetic changes. The relation-
ship between DNA methylation and aging is complex. Early stud-
ies suggested the occurrence of a global decrease in DNA
methylation associated with physiological aging (Wilson &
Jones, 1983). By contrast, other works have revealed that an
overall decrease in DNA methylation is not a common feature of
mammalian aging, and changes in this regard are circumscribed
to a specific subset of genes (Tawa et al., 1992; Tra et al., 2002;
Fuke et al., 2004). Further studies have even shown that several
loci in CpG islands gain methylation with age (Christensen et al.,
2009; Maegawa et al., 2010). To evaluate the putative occur-
rence of DNA-methylation alterations in Zmpste24) ⁄ ) progeroid
mice, we first analyzed by high-performance capillary electro-
phoresis (HPCE) the global 5-methylcytosine (5mC) content in
liver samples from these mutant mice. As shown in Fig. 1a, we
did not observe significant differences in global methylation
between Zmpste24) ⁄ ) and control mice. Likewise, we failed to
find significant methylation differences in subtelomeric regions
or in major satellites located in pericentromeric regions of DNA
from Zmpste24) ⁄ ) mice when compared with wild-type animals
(Fig. 1b).
To test the possibility that specific alterations in the methyla-
tion status of certain DNA loci rather than global changes in
DNA methylation, could be linked to the premature aging of
Zmpste24) ⁄ ) mice, we investigated the methylation pattern of
their ribosomal RNA-encoding genomic regions (rDNA), as sev-
eral works have shown that alterations in rDNA methylation
occur in aging (Johnson et al., 1998; Olson & Dundr, 2005).
Ribosomal RNA is synthesized as a 45S pre-rRNA, which is subse-
quently processed into 18S, 5.8S, 28S, and 5S mature rRNAs.
Interestingly, and as can be seen in Fig. 2, bisulfite sequencing
analysis revealed a significant trend to hypermethylation of the
rDNA units of Zmpste24) ⁄ ) mice, especially in internal regions
such as the 28S 5¢-region. Remarkably, two CpG sites located at
positions -133 and -144 in the Upstream Control Element (UCE)
of the rDNA promoter are hypermethylated in Zmpste24-defi-
cient animals (Fig. 2). Methylation of these two CpGs is suffi-
cient to inhibit the formation of the Pol I pre-initiation complex,
thus blocking rDNA transcription (Chen & Pikaard, 1997; Sant-
oro et al., 2002). Consistent with these results, qRT–PCR experi-
ments revealed a significant reduction in 45S pre-rRNA in
Zmpste24-deficient animals, which was reverted upon azaciti-
dine treatment (Fig. 3a), providing additional support to the
causal role of promoter hypermethylation in this alteration. We
next used chromatin immunoprecipitation to examine the
amounts of rDNA-associated RNA polymerase I. As shown in
Fig. 3b, while the levels of polymerase bound to the promoter
region are similar among wild-type and mutant animals, Zmp-
ste24) ⁄ ) mice show a 3-fold reduction in the levels of elongat-
ing RNA polymerase I associated with the rDNA coding regions.
Collectively, these results indicate that Zmpste24 deficiency
causes a severe dysfunction of rRNA gene activity, which could
be implicated in the premature cellular senescence and acceler-
ated aging phenotype observed in these mice (Varela et al.,
2005). In agreement with this possibility, rDNA hypermethyla-
tion has been reported to occur during physiological aging
in rats (Oakes et al., 2003), and a decrease in the rRNA gene
activity with age has also been observed in humans (Thomas &
Mukherjee, 1996).
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Loss of acetylated forms of nucleosome histones in
Zmpste24) ⁄ ) mice
Chromatin conformation and transcriptional control are influ-
enced not only by promoter methylation but also by histone
post-translational modifications, most notably site-specific
methylation and acetylation ⁄ deacetylation of histone tails
(Shahbazian & Grunstein, 2007). Interestingly, genes potentially
involved in the progeroid phenotype of Zmpste24-deficient
mice, such as p21WAF1 and INK4 ⁄ARF, have been described to
be regulated by histone acetylation (Archer et al., 1998; Matheu
et al., 2005). Consequently, we decided to investigate the modi-
fication status of histones in Zmpste24-deficient mice. As a first
approach to this aim, we used HPCE to analyze H2B and H4
acetylation status. As can be seen in Fig. 4a, Zmpste24-deficient
mice show a loss of about 15% of global acetylation in histone
H4, produced by a reduction in all its monoacetylated, diacety-
lated, and triacetylated forms. Likewise, and similar to the case
of histone H4, Zmpste24-deficient mice show an important
decrease (about 50%) in global acetylation of histone H2B
(Fig. 4b). This decrease mainly derives from a significant loss
(about 80%) of the monoacetylated form of H2B. To determine
the residue that could be target of this specific loss of acetyla-
tion, we carried out mass spectrometry analysis on this fraction.
As can be seen in Fig. 5a, we observed a clear decrease in the
relative abundance of a peptide corresponding to the first 12
amino acids of the protein which contain one acetyl group at
lysine 5, indicating that the loss of H2B monoacetylation occurs
mostly at this residue. This conclusion was further confirmed by
Western blot analysis with an antibody that specifically recog-
nizes this modification (Fig. 5b). This analysis also showed that
this decrease in histone acetylation is not restricted to the liver.
As can be seen in Fig. 5b, the same alteration was also present
in other tissues from Zmpste24-deficient mice.
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Fig. 1 Global DNA methylation analysis in Zmpste24) ⁄ ) mice. (a) Global 5-methyl-cytosine content analyzed by high-performance capillary electrophoresis
(HPCE) in liver samples from representative wild-type (N37C, N68B, and N75A) and Zmpste24-deficient mice (N45C, N74A, and N53C). (b) Analysis of the DNA
methylation status by bisulfite sequencing of multiple clones (see Experimental procedures) of subtelomeric repeats (left) and major satellites (right) in liver samples
from the same control and Zmpste24) ⁄ ) mice as in (a). Distribution of CpG sites within the amplified DNA is shown by vertical bars on and horizontal bar over
each panel. Three mice per genotype and 12 clones per mouse were analyzed. Methylated and unmethylated CpG positions are shown as black and white
squares, respectively.
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Acetyl-H2B-mediated differential gene regulation in
Zmpste24) ⁄ ) mice
The reduction of acetylated forms of nucleosome histones is
associated with a stronger association of these nucleosomes
with the DNA, which generates a more compacted or silent
chromatin state. We hypothesized that the decrease of histone
acetylation observed in Zmpste24) ⁄ ) mice could produce both a
general decrease in the transcriptional activity of their cells and a
deregulation of the expression of specific genes implicated in
the generation of the senescence phenotype observed in these
animals. Consequently, we performed two independent ChIP-
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Fig. 2 rDNA methylation analysis in Zmpste24) ⁄ ) mice. Analysis of DNA methylation at ribosomic DNA using bisulfite sequencing of multiple clones in liver
DNA samples from Zmpste24-deficient mice (N45C, N74A and N53C) and control littermates (N37C, N68B and N75A). Scheme showing the rRNA gene (top),
depicting the six regions subjected to methylation analysis (AF); these correspond to the proximal promoter (A-C), and the ends of 18S (D-E) and 28S (F) regions.
Three mice per genotype and twelve clones per mouse were analyzed. Methylated and unmethylated CpG positions are represented as black and white squares,
respectively.
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Fig. 3 Transcriptional activity of the rRNA gene in Zmpste24) ⁄ ) mice. (a) qRT–PCR quantification of the precursor rRNA transcript in liver samples from wild-type,
Zmpste24-deficient animals, and azacitidine-treated Zmpste24-deficient mice (AzaC) relative to the levels of 28S rRNA. (b) RNA polymerase I association with the
rDNA promoter and internal regions indicated at the top, as determined by chromatin immunoprecipitation of liver samples from Zmpste24) ⁄ ) mice and control
littermates. A schematic map of the rRNA gene is included at the top, indicating the position of the two analyzed regions. *P < 0.05. Error bars represent SEM.
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on-Chip experiments to determine specific genomic regions of
association of acetyl-H2B in both Zmpste24) ⁄ ) and control
mice. In the first experiment, we compared samples from a Zmp-
ste24) ⁄ ) mice with a control littermate, while for the second
experiment we used pools of genomic DNA obtained from three
wild-type and three mutant animals, respectively. A complete
list of all the probes that showed recurrent differences in enrich-
ment between Zmpste24-deficient and control samples can be
found in Tables S2 and S3 (Supporting information). Addition-
ally, and to determine if the putative differences in association
of acetyl-H2B to specific genomic regions of control and mutant
mice could modulate the expression of specific genes, we per-
formed transcriptional profiling on liver samples from a Zmp-
ste24) ⁄ ) mouse and a littermate control. For this purpose, we
isolated total liver RNA and used it for expression analysis by
ultra-deep RNA sequencing using an Illumina platform (Wilhelm
et al., 2008).
A list of key genes that were found recurrently enriched in the
samples belonging to control mice compared to Zmpste24) ⁄ )
mice and which also showed a reduced expression in Zmpste24-
mutant samples is shown in Table 1. Additional validation of
these results was performed by qRT–PCR, as shown in Fig. S1
(Supporting information). Interestingly, one of these genes is
Bcl6, a known inhibitor of the senescence process mediated by
p53 (Shvarts et al., 2002). The transcriptional down-regulation
of this gene can play a key role in the accelerated senescence
phenotype triggered by the activation of p53 observed in Zmp-
ste24-deficient mice. We also observed transcriptional down-
regulation associated with a decrease in the levels of acetyl-H2B
in several genes involved in fatty acid metabolism (Sec14p,
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Fig. 4 Histones H4 and H2B acetylation status in Zmpste24) ⁄ ) mice. (a) High-performance capillary electrophoresis (HPCE) analysis of histone H4 post-
translational modifications. Representative electropherograms show peaks corresponding to the nonacetylated (Ac0), mono- (Ac1), di- (Ac2), and triacetylated
(Ac3) forms of histone H4 in liver samples from wild-type (WT) and Zmpste24-deficient mice (left). Relative levels of acetylated histone H4 in two WT and three
mutant mice (right). (b) HPCE analysis of histone H2B post-translational modifications. Representative electropherograms corresponding to liver samples from WT
and Zmpste24-deficient mice are shown, along with samples from HL60 cells treated with the indicated concentrations of the histone deacetylase inhibitor
trichostatin A (TSA) (left). Electropherograms of samples treated with TSA show mono-, di-, tri-, and tetra-acetylated forms of histone H2B. Relative levels of
acetylated histone H2B in three WT and three mutant mice (right) are shown. *P < 0.05; ***P < 0.001. Error bars represent SEM.
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Elovl3, and Apoc1) and glycogen metabolism (Ppp1r3b and
Cmah). These alterations may contribute to the lipodystrophy
phenotype and the altered metabolic response previously
described in Zmpste24) ⁄ ) mice (Pendas et al., 2002; Marino
et al., 2008).
In addition to this general decrease in acetylation of the his-
tone H2B, we could also observe specific enrichment of acetyl-
H2B in several genes from Zmpste24-deficient samples. Some of
them are also transcriptionally up-regulated in these progeroid
mice. Remarkably, among these genes we have found Apcs
(Table S3, Supporting information) that has been reported to
control chromatin degradation and could be involved in the
chromatin abnormalities observed in Zmpste24) ⁄ ) cells (Bicker-
staff et al., 1999; Varela et al., 2005). Additionally, we have also
found acetyl-H2B-related up-regulation of known proliferation
inhibitors such as Agxt2l1 and Htatip2 that could contribute to
the senescence phenotype. Finally, several genes involved in liver
inflammation and detoxification were identified (Cyp2b10,
Cyp4a14, Orm1, Fmo2, and Fgl1). The up-regulation of these
genes could indicate that the liver from Zmpste24-deficient mice
is subjected to a kind of cellular stress that triggers an adaptive
metabolic response involving the activation of inflammation and
detoxification mechanisms in these progeroid mice.
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Fig. 5 H2B acetylation in lysine 5 in Zmpste24) ⁄ ) mice. (a) Mass spectrometry identification of the histone H2B residue differentially acetylated in wild-type vs.
Zmpste24) ⁄ ) mice. Identification of the peptide MPEPACKACSAPAPK indicates the presence of acetylated histone H2B at lysine 5 in control samples (left); this
peptide is not detected in Zmpste24) ⁄ ) mice (right). Control peptide is shown (*). (b) Western blot analysis of histone H2B acetylation in control and
Zmpste24-deficient. Histone H3 was used as a loading control.
Table 1 Genes recurrently enriched in either Zmpste24+ ⁄ + (upper half) or
Zmpste24) ⁄ ) (lower half) samples that also show changes in expression levels
Gene
ChIP on chip Analysis Expression Analysis
Enrichment P-value Zmpste24) ⁄ ) Zmpste24+ ⁄ +
Elovl3 2.399 0.011 0.38 335.02
Cmah 2.188 0.012 0.28 1.82
Ifi47 2.117 0.003 1.94 5.17
6430527G18Rik 2.100 0.011 1.02 2.37
Sec14l2 2.044 0.009 20.69 88.66
Bcl6 1.895 0.002 3.56 6.87
Apoc1 1.689 0.006 2639.22 6902.38
Ppp1r3b 1.622 0.005 3.27 21.41
Cyp2b10 3.579 0.026 70.84 0.11
Fmo2 3.293 0.014 1.75 0.23
Apcs 3.278 0.007 803.57 71.87
Htatip2 2.775 0.009 31.87 5.11
Cyp4a14 2.684 0.019 65.31 5.02
Fgl1 2.554 0.009 1007.95 119.41
Agxt2l1 2.162 0.012 114.41 6.16
Orm1 2.111 0.007 4201.28 528.02
The enrichment value refers to the ratio between the enrichment ratios
obtained in Zmpste24-deficient and control samples. Control vs.
Zmpste24) ⁄ ) in the upper half and Zmpste24) ⁄ ) vs. control in
the lower half.
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Discussion
Hutchinson–Gilford progeria syndrome is a premature aging
disease characterized by a rapid progression of symptoms such
as hair loss, growth retardation, lack of subcutaneous fat,
aged-looking skin, osteoporosis, and arteriosclerosis. Patients
with HGPS usually die at around 13 years and there is no spe-
cific treatment for them (Navarro et al., 2006). Accordingly,
analysis of the molecular pathways implicated in the develop-
ment of this disease has been necessary for developing thera-
peutic approaches for these patients (Espada et al., 2008;
Varela et al., 2008). In this scenario, Zmpste24-deficient mice,
which also accumulate a farnesylated lamin A precursor, have
become an excellent tool for the molecular study of progeria.
The use of these mice has allowed to demonstrate that the
accumulation of farnesylated prelamin A causes alterations in
nuclear structure and chromatin organization, which in turn
activate DNA damage sensor pathways that finally lead to the
development of the progeroid phenotypes characteristic of
Zmpste24-mutant mice (Liu et al., 2005; Varela et al., 2005).
Nevertheless, the molecular links between the chromatin disor-
ganization and the transcriptional alterations present in these
progeroid mice remain unknown. In this work, we report the
presence of epigenetic alterations in Zmpste24-deficient mice
which are related to those observed in physiologically aged
mice. We also propose that these epigenetic abnormalities
may be implicated in the development of the progeroid
phenotype.
Previous studies have reported a significant decrease in global
DNA methylation with aging (Wilson & Jones, 1983; Richardson,
2003; Fuke et al., 2004). By contrast, this trend was not
observed in our progeroid animal model, in which the total
methylcytosine content did not differ significantly from that of
control mice. These differences between methylation changes in
physiological and accelerated aging could derive from the fact
that the loss of global DNA methylation during physiological
aging mainly results of the passive demethylation of heterochro-
matic DNA, because of a progressive loss of efficacy of DNA
methyltransferase 1 (Dnmt1) or to the erroneous targeting of
this enzyme by other cofactors (Casillas et al., 2003). The short-
ened lifespan of Zmpste24-deficient mice, which develop an evi-
dent progeroid phenotype before the decline in Dnmt1 activity
occurs, could contribute to explain the absence of global DNA
demethylation in this animal model of accelerated aging. Never-
theless, it is remarkable that, in accordance with our observa-
tions in this progeroid animal model, a number of works have
reported that an aging-associated decline in total methylcyto-
sine content is not a common finding in mammalian tissues
(Tawa et al., 1992; Tra et al., 2002; Fuke et al., 2004). Further-
more, very recent studies have demonstrated that several loci
present in CpG islands gain methylation with age (Christensen
et al., 2009; Maegawa et al., 2010), pointing to the need of
detailed analysis of specific genes in specific tissues before rais-
ing definitive conclusions about the relevance of methylation
changes during normal and pathological aging.
Consistent with this possibility, and in contrast to the absence
of alterations in global methylation, we observed a marked
hypermethylation of the rDNA loci in Zmpste24) ⁄ ) progeroid
mice. This epigenetic mark has been previously described in
physiological aging but its precise relevance in this process is
largely unknown (Oakes et al., 2003). Our observation that
rDNA hypermethylation also occurs in the context of accelerated
aging suggests that it could be functionally involved in the
development of age-associated phenotypes and consequently
it could provide a potential target of anti-progeroid therapies.
We hypothesize that down-regulation of rDNA transcription
resulting from promoter hypermethylation plays a crucial role in
the cellular senescence phenotype observed in both accelerated
and physiological aging. Supporting this proposal, it has been
described that rDNA hypermethylation is associated with pro-
gression-free survival in ovarian and endometrial cancer (Powell
et al., 2002; Chan et al., 2005).
In relation to histone modifications, we describe herein that
Zmpste24-deficient mice present hypoacetylation of histones
H2B and H4, which in the case of H2B mostly occurs in the
monoacetylated form modified at lysine 5. Although the signifi-
cance of this loss of acetylation is still unclear, the general trend
to a loss of histone acetylation suggests a switch of chromatin
structure to a close, inactive conformation, characteristic of qui-
escent or senescent cellular states, which could contribute to the
cellular phenotype observed in these mice. Alternatively, histone
modifications can promote specific promoter methylation and
regulate DNA transcription even in the absence of methylation,
as described in the case of CDKN1A locus (Archer et al., 1998;
Richon et al., 2004). Finally, we have found a direct correlation
between loss of acetylated forms of histone H2B and transcrip-
tional down-regulation of several genes involved in the control
of proliferation ⁄ senescence such as Bcl6, Apcs, or Htatip2,
which can contribute to the senescence phenotype observed in
the context of Zmpste24 deficiency (Varela et al., 2005, 2008).
Additionally, the expression of other genes involved in fatty acid
and glycogen metabolism is also altered and can contribute to
the systemic defects described in Zmpste24) ⁄ ) mice (Marino
et al., 2008). Also in this regard, we must emphasize that other
histone modifications distinct from loss of H2B and H4 acetyla-
tion can also contribute to the multiple alterations observed in
the Zmpste24) ⁄ ) progeroid mice and further studies will be
required to clarify this question. Nevertheless, the identification
of a series of genes with marked expression changes associated
with specific histone modifications in tissues from Zmpste24) ⁄ )
mice may help to further clarify the molecular mechanisms
underlying aging and progeroid syndromes and to define new
targets for the treatment of these devastating diseases.
Experimental procedures
Animals
Face1 ⁄ Zmpste24-deficient mice were generated and genotyped
as described (Pendas et al., 2002). For in vivo inhibition of DNA
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methylation, 5-azacitidine (2 mg Kg)1 day)1) in PBS was admin-
istrated intraperitoneally to mice every day for 1 week. Four
month-old Face1 ⁄ Zmpste24-deficient mice and littermate con-
trols were sacrificed by cervical dislocation, and their livers were
extracted and stored at )80C until further use. All the proce-
dures were carried out following the guidelines of the animal
facility of the Universidad de Oviedo.
Analysis of sequence-specific DNA methylation
The methylation status of specific genomic DNA sequences was
established by bisulfite genomic sequencing (Fraga et al., 2005).
Following the bisulfite conversion reaction, the DNA sequence
was amplified by PCR with primers specific for the bisulfite-
converted DNA. The PCR product was cloned and at least
ten colonies per sequence were sequenced automatically to
determine the methylation status of each sample. The percent-
age of methylation for each sample was calculated based on the
number of clones that showed methylated or unmethylated
cytosines. Primer sequences are available as Table S1 (Support-
ing information).
Quantification of global DNA methylation
5-Methylcytosine (5mC) genomic content was determined by
HPCE, as described (Fraga et al., 2002). Briefly, genomic DNA
samples were boiled, treated with nuclease P1 (Sigma, St. Quen-
tin Fallavier, France) for 16 h at 37C and with alkaline phospha-
tase (Sigma, St. Quentin Fallavier, France) for an additional 2 h
at 37C. After hydrolysis, total cytosine and 5mC content
were measured by HPCE using a P ⁄ACE MDQ system (Beckman-
Coulter, Beckman-Coulter, Fullerton, CA, USA). Cytosine and
methylcytosine were separated and quantified using the sodium
dodecylsulfate (SDS) micelle system, based on size, charge,
structure, and hydrophobicity differences after the application
of specific voltages using a narrow-bore fused silica capillary
tube. Relative 5mC content was expressed as a percentage of
total cytosine content (methylated and nonmethylated).
Quantification of histone acetylation
Histones were prepared in accordance with established proto-
cols (Turner & Fellows, 1989) and global acetylation at histones
H2B and H4 was quantified as previously described (Fraga et al.,
2005). Individual histone fractions were extracted from cell
nuclei by acid treatment, and then purified by reverse-phase
high performance liquid chromatography (HPLC) on a Jupiter
C18 column (Phenomenex Inc., Torrance, CA, USA) with an
acetonitrile gradient (20)60%) in 0.3% trifluoroacetic acid,
using a HPLC gradient system (Beckman-Coulter). This method
separates molecules based on their hydrophobicity. Samples
were lyophilized and then dissolved in 5 mM DTT to avoid oxi-
dation. Acetylated histone derivatives were resolved by HPCE as
described (Fraga et al., 2005). In brief, nonacetylated, mono-,
di- and polyacetylated histone derivatives were resolved by
HPCE. An uncoated fused silica capillary (60.2 cm · 75 lm,
effective length 50 cm; Beckman-Coulter) was used in a CE
system (P ⁄ACE MDQ; Beckman-Coulter) connected to a data-
processing station (32 Karat Software; Beckman-Coulter). The
running buffer was 100 mM phosphate buffer, pH 2.0 contain-
ing 0.02% (w ⁄ v) HPM-cellulose, and running conditions were
25C with operating voltages of 12 kV. On-column absorbance
was monitored at 214 nm. Before each run, the capillary system
was conditioned by washing with 0.1 M NaOH (3 min), with
0.5 M H2SO4 (2 min), and equilibrated with running buffer
(3 min). Samples were injected under pressure (0.3 psi, 3 s). All
samples were analyzed in duplicate and three measurements
were made per replicate.
Nano-liquid chromatography and tandem mass
spectrometry
The resulting H2B-derived tryptic peptides from control and
mutant samples were on line injected onto a C18 reversed-phase
micro-column (300 mm ID · 5 mm PepMapTM; LC Packings,
Amsterdam, The Netherlands) to remove salts, and then ana-
lyzed in a continuous acetonitrile gradient consisting of 0–50%
B in 45 min and 50–90% B in 1 min (B = 95% acetonitrile,
0.5% acetic acid in water) on a C18 reversed-phase nano-
column (100 mm ID · 15 cm, Discovery; BIO Wide pore, Supe-
lco, Bellafonte, PA, USA). A flow-rate of 300 nL min)1 was used
to elute peptides from the reversed-phase nano-column to a
PicoTip emitter nano-spray needle (New Objective, Woburn,
MA, USA) for real-time ionization and peptide fragmentation on
a 4000 Q-Trap LC ⁄MS ⁄MS system (Applied Biosystems ⁄MDS
Sciex, Concord, ON, Canada) equipped with a nanospray ion
source (Protana, Ontario, Canada). Nano-liquid chromatography
was automatically performed on an advanced nano-gradient
generator (Ultimate nano-HPLC; LC Packings) coupled to an
autosampler (Famos; LC Packings). The needle voltage was set at
3000 V. Nitrogen was used as curtain (value of 15) and collision
gas (set to high). For the analysis, in the multiple reaction moni-
toring mode (MRM), Q1 was set on the multiply charged parent
ions at the indicated m ⁄ z values. Q3 was set on the marker filter-
ing signal selected for each parent ion. Collision energy was set
to 20. All chromatograms and MS ⁄MS spectra were analyzed by
the software packages Analyst 1.4.1 (Applied Biosystems).
ChIP-on-Chip and data analysis
The chromatin immunoprecipitation assay was carried out as
described (Fraga et al., 2005) with anti-acK5H2b (Cell Signal-
ing). DNA-protein interactions were fixed using formaldehyde as
a crosslinking agent. Crosslinked protein ⁄ chromatin was frag-
mented by sonication into fragments of 200–800 bp. Protein
was then immunoprecipitated from the lysate using a specific
antibody. After reversal of crosslinking, proteins were removed,
DNA purified and used for ChIP-on-Chip assays. The ChIP on
Chip assay was performed on the Agilent Mouse Promoter
ChIP-on-chip microarrays with Designs IDs 014716 and 014717
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containing probes covering 5.5 kb upstream and 2.5 kb down-
stream of the transcriptional start sites. Labeling was performed
using a BioPrime Total Genomic Labelling System (Invitrogen,
Carlsbad, CA, USA) following manufacturer instructions. The
hybridization was performed following Agilent manual G4481-
90010. The arrays were scanned on a G2565BA DNA microarray
scanner (Agilent) and the images were quantified using Agilent
Feature Extraction Software v9.5.3. Finally, Agilent ChIP Analyt-
ics v1.3.1 was used as analysis software using Whitehead model
v1.0 as error model.
RNA sequencing
Transcriptional profiling of livers from Zmpste24-deficient and
control mice was performed by RNA sequencing. Briefly, total
RNA was used for cDNA synthesis and sequenced at The Centre
for Applied Genomics, The Hospital for Sick Children, Toronto,
Canada, using a GAII instrument following the manufacturer
instructions (Illumina). Reads were mapped to the mouse refer-
ence genome (mm9) using TopHat and Bowtie (Trapnell et al.,
2009), and gene expression was computed using Cufflinks
(Trapnell et al., 2010) and mouse gene models from Ensembl
v56. Relative expression was expressed as RPKM values (Reads
Per Kilobase of transcript per Million mapped reads).
Western blotting
Mice tissues were immediately frozen in liquid nitrogen after
extraction and were homogenized in a 20 mM Tris buffer pH
7.4, containing 150 mM NaCl, 1% Triton X-100, 10 mM EDTA,
and Complete protease inhibitor cocktail (Roche Applied Sci-
ence, Indianapolis, IN, USA). Once homogenized, tissue extracts
were centrifuged at 12 000 g at 4C and supernatants were
collected. The protein concentration of the supernatant was
evaluated by bicinchoninic acid technique (BCA protein assay
kit; Pierce Biotechnology, Rockford, IL, USA); 25 lg of protein
sample was loaded on 13% SDS-polyacrylamide gels. After
electrophoresis, gels were electrotransferred onto nitrocellulose
filters, and then the filters were blocked with 5% nonfat dried
milk in PBT (phosphate-buffered saline with 0.05% Tween 20)
and incubated with anti-acK5H2b (Cell Signaling) and anti-H3
(Abcam) antibodies in 5% BSA in PBT. After three washes with
PBT, filters were incubated with the corresponding secondary
antibody at 1:10000 dilution in 1.5% milk in PBT and developed
with Immobilon Western Chemiluminescent HRP substrate
(Millipore).
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Fig. S1 Differential expression of genes associated with acety-
lated histone H2B in Zmpste24-deficient and control mice. RNA
levels corresponding to a selection of genes found to be differ-
entially expressed by ultra-deep RNA sequencing were studied
by qRT–PCR with specific Taqman probes. (a) Genes up-regu-
lated in control mice. (b) Genes down-regulated in Zmpste24-
deficient mice. *P < 0.05; **P < 0.01; ***P < 0.001. Error bars
represent SEM.
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